Evaluating palmitoyl-protein thioesterase 1 in oral squamous cell carcinoma: A novel indicator of tumor behavior and therapeutic response

doi:10.5493/wjem.v15.i4.110917

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

(46)

(58)

(0)

(14)

(664)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Exp Med. Dec 20, 2025; 15(4): 110917
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110917

Full Size Figure Download Figure

Figure 1 Flowchart showing the mechanism of action of palmitoyl-protein thioesterase 1 during dysregulation and inhibition. PPT1: Palmitoyl-protein thioesterase 1.

Citation: Kumar KCP, Sahoo S, Adhya AK, Gaikwad MR, Ganapathy A, Ravi PK. Evaluating palmitoyl-protein thioesterase 1 in oral squamous cell carcinoma: A novel indicator of tumor behavior and therapeutic response. World J Exp Med 2025; 15(4): 110917
URL: https://www.wjgnet.com/2220-315x/full/v15/i4/110917.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i4.110917

Kumar KCP, Sahoo S, Adhya AK, Gaikwad MR, Ganapathy A, Ravi PK. Evaluating palmitoyl-protein thioesterase 1 in oral squamous cell carcinoma: A novel indicator of tumor behavior and therapeutic response. World J Exp Med 2025; 15(4): 110917 [PMID: 41497672 DOI: 10.5493/wjem.v15.i4.110917]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.